Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Debt / NOTE 2.500% 2/1
-
Number of holders
-
30
-
Total principal
-
182M
-
Principal change
-
-14.7M
-
Total reported value, excl. options
-
$229M
-
Value change
-
-$21M
-
Number of buys
-
11
-
Number of sells
-
-12
-
Price
-
$1.26
Significant Holders of AMAG PHARMACEUTICALS INC - NOTE 2.500% 2/1 as of Q4 2015
29 filings reported holding 00163UAA4 - AMAG PHARMACEUTICALS INC - NOTE 2.500% 2/1 as of Q4 2015.
AMAG PHARMACEUTICALS INC - NOTE 2.500% 2/1 has 30 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $182M of principal
.
Largest 10 bondholders include WOLVERINE ASSET MANAGEMENT LLC ($21.7M of principal), Castle Creek Arbitrage, LLC ($20.7M of principal), PUTNAM INVESTMENTS LLC ($19.1M of principal), CITADEL ADVISORS LLC ($17.5M of principal), Hutchin Hill Capital, LP ($14.3M of principal), BARCLAYS PLC ($11.2M of principal), Calamos Advisors LLC ($10M of principal), Polar Asset Management Partners Inc. ($10M of principal), Pine River Capital Management L.P. ($6.5M of principal), and CSS LLC/IL ($6.5M of principal).
This table shows the top 30 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.